
Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

